Mevasseret Zion, Israel

Yinon Ben Neriah

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yinon Ben Neriah: Innovator in Pharmaceutical Chemistry

Introduction

Yinon Ben Neriah is a notable inventor based in Mevasseret Zion, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyrazole pyrimidine derivatives. With a total of 2 patents, his inventions focus on addressing critical health issues.

Latest Patents

Yinon Ben Neriah's latest patents include the development of pyrazole pyrimidine derivatives that inhibit Casein kinase I (CKI) and Interleukin-1 receptor-associated kinase 1 (IRAKI). These inventions provide methods for their manufacture, compositions comprising them, and their uses in treating malignant diseases and disorders, as well as inflammatory diseases and disorders. His work represents a significant advancement in therapeutic options for these conditions.

Career Highlights

Throughout his career, Yinon has worked with prominent organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Biotheryx, Inc. His experience in these companies has allowed him to further his research and development efforts in the pharmaceutical sector.

Collaborations

Yinon has collaborated with notable colleagues such as Guy Brachya and Ido Burstain. These partnerships have contributed to the success of his projects and the advancement of his inventions.

Conclusion

Yinon Ben Neriah is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…